May 15, the U.S. Food and Drug Administration (FDA) approved a new use for Simponi (golimumab) injection: to treat adults with moderate to severe ulcerative colitis. Read more.
FDA approves Simponi for ulcerative colitis
Author(s):
© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.